Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9327505 | Gynecologic Oncology | 2005 | 5 Pages |
Abstract
We found that p16 was more frequently and more strongly expressed in LMS compared to STUMP and leiomyoma. We therefore concluded that p16 might play an important role in sarcomagenesis. Furthermore, p16 might be a useful immunohistochemical marker, which could help to distinguish cases of smooth muscle tumors in which histologic features are ambiguous or borderline, but the use of p16 in a diagnostic setting should await further clinical studies and clarification of the mechanisms.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Barbara Bodner-Adler, Klaus Bodner, Klaus Czerwenka, Oliver Kimberger, Sepp Leodolter, Klaus Mayerhofer,